Cargando…
Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
Breast cancer and cardiovascular diseases (CVD) represent significant global health challenges, with CVD being the leading cause of mortality and breast cancer, showing a complex pattern of incidence and mortality. We explore the intricate interplay between these two seemingly distinct medical condi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671526/ https://www.ncbi.nlm.nih.gov/pubmed/38003690 http://dx.doi.org/10.3390/ijms242216500 |
_version_ | 1785149426874974208 |
---|---|
author | Boutas, Ioannis Kontogeorgi, Adamantia Kalantaridou, Sophia N. Dimitrakakis, Constantine Patsios, Panagiotis Kalantzi, Maria Xanthos, Theodoros |
author_facet | Boutas, Ioannis Kontogeorgi, Adamantia Kalantaridou, Sophia N. Dimitrakakis, Constantine Patsios, Panagiotis Kalantzi, Maria Xanthos, Theodoros |
author_sort | Boutas, Ioannis |
collection | PubMed |
description | Breast cancer and cardiovascular diseases (CVD) represent significant global health challenges, with CVD being the leading cause of mortality and breast cancer, showing a complex pattern of incidence and mortality. We explore the intricate interplay between these two seemingly distinct medical conditions, shedding light on their shared risk factors and potential pathophysiological connections. A specific connection between hypertension (HTN), atrial fibrillation (AF), myocardial infarction (MI), and breast cancer was evaluated. HTN is explored in detail, emphasizing the role of aging, menopause, insulin resistance, and obesity as common factors linking HTN and breast cancer. Moreover, an attempt is made to identify the potential impact of antihypertensive medications and highlight the increased risk of breast cancer among those women, with a focus on potential mechanisms. A summary of key findings underscores the need for a multisystem approach to understanding the relationship between CVD and breast cancer is also explored with a highlight for all the gaps in current research, such as the lack of clinical observational data on MI and breast cancer in humans and the need for studies specifically designed for breast cancer. This paper concludes that there should be a focus on potential clinical applications of further investigation in this field, including personalized prevention and screening strategies for women at risk. Overall, the authors attempt to provide a comprehensive overview of the intricate connections between breast cancer and cardiovascular diseases, emphasizing the importance of further research in this evolving field of cardio-oncology. |
format | Online Article Text |
id | pubmed-10671526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106715262023-11-19 Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature Boutas, Ioannis Kontogeorgi, Adamantia Kalantaridou, Sophia N. Dimitrakakis, Constantine Patsios, Panagiotis Kalantzi, Maria Xanthos, Theodoros Int J Mol Sci Review Breast cancer and cardiovascular diseases (CVD) represent significant global health challenges, with CVD being the leading cause of mortality and breast cancer, showing a complex pattern of incidence and mortality. We explore the intricate interplay between these two seemingly distinct medical conditions, shedding light on their shared risk factors and potential pathophysiological connections. A specific connection between hypertension (HTN), atrial fibrillation (AF), myocardial infarction (MI), and breast cancer was evaluated. HTN is explored in detail, emphasizing the role of aging, menopause, insulin resistance, and obesity as common factors linking HTN and breast cancer. Moreover, an attempt is made to identify the potential impact of antihypertensive medications and highlight the increased risk of breast cancer among those women, with a focus on potential mechanisms. A summary of key findings underscores the need for a multisystem approach to understanding the relationship between CVD and breast cancer is also explored with a highlight for all the gaps in current research, such as the lack of clinical observational data on MI and breast cancer in humans and the need for studies specifically designed for breast cancer. This paper concludes that there should be a focus on potential clinical applications of further investigation in this field, including personalized prevention and screening strategies for women at risk. Overall, the authors attempt to provide a comprehensive overview of the intricate connections between breast cancer and cardiovascular diseases, emphasizing the importance of further research in this evolving field of cardio-oncology. MDPI 2023-11-19 /pmc/articles/PMC10671526/ /pubmed/38003690 http://dx.doi.org/10.3390/ijms242216500 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Boutas, Ioannis Kontogeorgi, Adamantia Kalantaridou, Sophia N. Dimitrakakis, Constantine Patsios, Panagiotis Kalantzi, Maria Xanthos, Theodoros Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature |
title | Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature |
title_full | Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature |
title_fullStr | Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature |
title_full_unstemmed | Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature |
title_short | Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature |
title_sort | reverse onco-cardiology: what is the evidence for breast cancer? a systematic review of the literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671526/ https://www.ncbi.nlm.nih.gov/pubmed/38003690 http://dx.doi.org/10.3390/ijms242216500 |
work_keys_str_mv | AT boutasioannis reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature AT kontogeorgiadamantia reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature AT kalantaridousophian reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature AT dimitrakakisconstantine reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature AT patsiospanagiotis reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature AT kalantzimaria reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature AT xanthostheodoros reverseoncocardiologywhatistheevidenceforbreastcancerasystematicreviewoftheliterature |